Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise snack program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > People > Professor Warwick Britton AO

Professor Warwick Britton AO

Head of Tuberculosis Research Program

Bosch Professor of Medicine, and Professor of Immunology, Sydney Medical School, University of Sydney

Consultant Physician, Department of Clinical Immunology, Royal Prince Alfred Hospital

Programs

  • Tuberculosis Research Program

Phone number Phone Number +61 2 9565 6263

Email Email w.britton@centenary.org.au

Profile Linkedin Profile

Research Interests
Recently, he initiated new collaborative research programs in Vietnam on improving the control of tuberculosis and on immunogenetics of tuberculosis.

Achievements

Since 1997 his group has used an aerosol model of infection with virulent M. tuberculosis in a dedicated PC3 facility in the Centenary Institute. This has allowed them to analyse the cellular and cytokine control of M. tuberculosis infection in the lungs using genetically modified mice and to develop novel subunit and recombinant BCG vaccines to prevent infection with M. tuberculosis.

In addition, his group has identified a new secreted enzyme of M. tuberculosis, which is a novel target for drug development. Professor Britton has a longstanding research interest in the epidemiology and immunology of asthma and established a long-running cohort on childhood asthma in 1982.

Themes

  • Inflammation

    Inflammation

Research Fields

  • Tuberculosis

Topics

  • Infectious diseases ,

Publications

Recent publications

Search amongst our repository

all publications

For access to all Publications via Pub Med.

News

  • Grant supports new COVID-19 nasal vaccine research

    Research led by the Centenary Institute and the University of Sydney – focused on the development of a new nasal COVID-19 vaccine – has received close to $1m in grant funding from the NSW COVID-19 Vaccine Acceleration Research Grants Program.
    Date 22 Dec 2022
  • New nasal vaccine strategy could improve COVID-19 protection

    Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.
    Date 16 Nov 2022
    Dr Anneliese Ashhurst respiratory researcher Dr Anneliese Ashhurst respiratory researcher
  • New vaccine research aims to conquer TB

    The Centenary Institute and the University of Sydney, together with collaborators, have been awarded an AU$19 million contract from the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH), to develop the next generation of tuberculosis (TB) vaccines.
    Date 29 Sep 2022
    Professor Warwick Britton AO, is lead investigator on Tuberculosis Professor Warwick Britton AO, is lead investigator on Tuberculosis
  • World TB Day seminar hosted at the Centenary Institute

    The Centre of Research Excellence in Tuberculosis Control (TB-CRE) has held a seminar at the Centenary Institute in support of World TB Day, 24 March 2022. TB, primarily affecting the lungs, is one of the world’s deadliest infectious killers. Every day, over 4,100 people die from TB world-wide and nearly 30,000 people fall ill with ...
    Date 25 Mar 2022
  • $2m NHMRC success for Centenary Institute researchers

    Centenary Institute researchers have secured more than $2m in collective funding from the Federal Government in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.
    Date 03 Nov 2021
  • Pathway to eliminating antibiotic-resistant tuberculosis in the Pacific

    Australian researchers, including from the Centenary Institute have been awarded funding for a major project that aims to eliminate both active and latent tuberculosis (TB) found on Kiribati, an island nation in the central Pacific Ocean. The project will also support multidrug-resistant TB control education and management through the Pacific region.
    Date 30 Jun 2020
  • Exciting new vaccine targets killer disease TB

    Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis (TB), the world’s top infectious disease killer. Reported in the ‘Journal of Medicinal Chemistry’, the early-stage vaccine was shown to provide substantial protection against TB in a pre-clinical laboratory setting. “Tuberculosis ...
    Date 22 Aug 2019
View all

Twitter

Tweets by CentenaryInst Follow us (links open in a new window)

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram